Skip to main content
2025 CRT Conference Main banner
Back

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI

Professor of Cardiology and Population Health Science and Policy, Mount Sinai Endowed Professor in Cardiovascular Clinical Research and Outcomes; Director of Interventional Cardiovascular Research and Clinical Trials; Director of Women’s Heart and Vascular Center at Mount Sinai Heart
Icahn School of Medicine at Mount Sinai, New York
New York, New York, United States

Dr. Roxana Mehran is an internationally renowned interventional cardiologist and clinical research expert in the field of cardiovascular disease. With over 1,600 peer-reviewed articles and a position on the ACC Board of Trustees, her influence is profound. For a decade. She is listed as Clarivate Analytics Most Cited Researchers – Top 1%, and Thomson Reuters list of The World’s Most Influential Scientific Minds.
As a principal investigator for numerous global studies and a key member of clinical guidelines committees, Dr. Mehran's expertise is widely recognized. She founded the Cardiovascular Research Foundation (CRF) and leads the Lancet Women and CVD Commission, addressing research gaps in women's cardiovascular health. Additionally, she established Women as One to empower women in medicine. On March 14th, 2024 she is honored with the prestigious Jacobi Medal from Icahn School of Medicine at Mount Sinai.

Disclosure(s): Abbott, Alleviant Medical, Beth Israel Deaconess Medical Center, Concept Medical, Cordis, Elixir Medical, Faraday Pharmaceuticals, Idorsia Pharmaceuticals, Janssen, MedAlliance, Mediasphere Medical, Medtronic, Novartis, Protembis GmbH, Sanofi, RM Glo: Grant/Research Support (Ongoing); AMA - JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elixir Medical, Stel, ControlRad (spouse): Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Elixir Medical, IQVIA, Medtronic, Medscape/WebMD Global, NovoNordisk: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director): SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director) (Ongoing)

Presentation(s):

Email Roxana